tiprankstipranks
Advertisement
Advertisement

FBRX Stock Latest News

First Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush
The FlyFirst Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush
6d ago
ARGX
FBRX
Argenx price target raised to $1,050 from $1,000 at Wedbush
PremiumThe Fly
Argenx price target raised to $1,050 from $1,000 at Wedbush
6d ago
ARGX
FBRX
First Tracks Biotherapeutics price target raised to $55 from $30 at Wells Fargo
PremiumThe Fly
First Tracks Biotherapeutics price target raised to $55 from $30 at Wells Fargo
6d ago
FBRX
TRAX
Forte Biosciences downgraded to Equal Weight from Overweight at Barclays
PremiumThe Fly
Forte Biosciences downgraded to Equal Weight from Overweight at Barclays
6d ago
FBRX
After Forte acquisition, H.C. Wainwright says First Tracks could be target
PremiumThe Fly
After Forte acquisition, H.C. Wainwright says First Tracks could be target
7d ago
ARGX
FBRX
Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
PremiumThe FlyMidday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
7d ago
F
GM
Forte Biosciences downgraded to Hold from Buy at Brookline
Premium
The Fly
Forte Biosciences downgraded to Hold from Buy at Brookline
7d ago
FBRX
Forte Biosciences downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Forte Biosciences downgraded to In Line from Outperform at Evercore ISI
7d ago
ARGX
FBRX
Video: Jefferies more bullish on Ford and GM
PremiumThe Fly
Video: Jefferies more bullish on Ford and GM
7d ago
F
T
Morning Movers: Ensign Group surges following second quarter results
PremiumThe Fly
Morning Movers: Ensign Group surges following second quarter results
7d ago
AMR
AZN
Forte Biosciences downgraded to Hold from Buy at TD Cowen
PremiumThe Fly
Forte Biosciences downgraded to Hold from Buy at TD Cowen
7d ago
FBRX
M&A News: Forte Biosciences Shares Leap 40% After Argenx Seals $2.2B Immunology Deal
PremiumMarket News
M&A News: Forte Biosciences Shares Leap 40% After Argenx Seals $2.2B Immunology Deal
7d ago
ARGX
FBRX
Forte Biosciences to be acquired by argenx
PremiumCompany AnnouncementsForte Biosciences to be acquired by argenx
7d ago
8K
FBRX
Argenx to acquire Forte Biosciences for $77 per share in cash
Premium
The Fly
Argenx to acquire Forte Biosciences for $77 per share in cash
7d ago
ARGX
FBRX
Forte Biosciences initiated with an Overweight at Barclays
Premium
The Fly
Forte Biosciences initiated with an Overweight at Barclays
13d ago
FBRX
Why Is Forte Biosciences (FBRX) Stock Up Today?
PremiumMarket News
Why Is Forte Biosciences (FBRX) Stock Up Today?
24d ago
FBRX
First Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright
PremiumThe Fly
First Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright
24d ago
FBRX
TRAX
Midday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’
PremiumThe Fly
Midday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’
25d ago
ASX
AZN
Forte Biosciences trading resumes
PremiumThe Fly
Forte Biosciences trading resumes
25d ago
FBRX
Forte Biosciences trading halted, volatility trading pause
PremiumThe FlyForte Biosciences trading halted, volatility trading pause
25d ago
FBRX
Forte Biosciences Reports Positive Phase 1b Vitiligo Results
Premium
Company Announcements
Forte Biosciences Reports Positive Phase 1b Vitiligo Results
25d ago
8K
FBRX
Forte Biosciences’ FB102 shows efficacy in vitiligo Phase 1b study
Premium
The Fly
Forte Biosciences’ FB102 shows efficacy in vitiligo Phase 1b study
25d ago
FBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >